PRODUCT INTRODUCTION
Armilon 1mg Tablet is a medication primarily composed of the active ingredient, Armilon. Armilon belongs to a class of drugs called benzodiazepines, which act on the brain and nerves (central nervous system) to produce a calming effect. These tablets are typically round, white, and come in a blister pack for oral administration.
USES OF ARMILON 1MG TABLET
Armilon 1mg Tablet finds its utility across various medical conditions, primarily due to its anxiolytic (anxiety-reducing), sedative, and muscle-relaxing properties. Here are some common applications:
- Anxiety Disorders: Armilon 1mg Tablet is often prescribed to manage symptoms of generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. It helps alleviate feelings of worry, nervousness, and tension.
- Insomnia: Individuals experiencing difficulty falling asleep or staying asleep may benefit from Armilon 1mg Tablet’s sedative effects. It can promote relaxation and aid in initiating and maintaining sleep.
- Muscle Spasms: This medication is sometimes used as an adjunct therapy in the treatment of muscle spasms or muscle rigidity associated with conditions like multiple sclerosis or cerebral palsy.
- Alcohol Withdrawal: Armilon 1mg Tablet may be utilized during alcohol withdrawal to manage symptoms such as agitation, tremors, and seizures. It helps alleviate the physiological and psychological distress associated with alcohol cessation.
BENEFITS OF ARMILON 1MG TABLET
- Effective Anxiety Relief: Armilon 1mg Tablet provides efficient relief from symptoms of anxiety, allowing individuals to function better in their daily lives and reducing the impact of anxiety on overall well-being.
- Improved Sleep Quality: By promoting relaxation and aiding in sleep initiation, Armilon 1mg Tablet can enhance sleep quality, leading to better restorative rest and improved daytime functioning.
- Muscle Relaxation: For individuals experiencing muscle spasms or stiffness, Armilon 1mg Tablet offers relief by relaxing muscles, thereby reducing discomfort and improving mobility.
- Support During Alcohol Withdrawal: Armilon 1mg Tablet can mitigate the discomfort and potential dangers associated with alcohol withdrawal, making the process safer and more manageable for individuals seeking to quit alcohol consumption.
SIDE EFFECTS OF ARMILON 1MG TABLET
While Armilon 1mg Tablet can be beneficial, like any medication, it may cause side effects in some individuals. Common side effects may include:
- Drowsiness: One of the most common side effects of Armilon 1mg Tablet is drowsiness or sedation, which can impair cognitive and motor functions. It’s important to avoid activities requiring mental alertness, such as driving, until the effects of the medication are known.
- Dizziness: Some individuals may experience dizziness or lightheadedness, especially when standing up quickly from a sitting or lying position. This effect can increase the risk of falls, particularly in older adults.
- Weakness: Armilon 1mg Tablet may cause feelings of weakness or fatigue, impacting energy levels and physical stamina.
- Confusion: In some cases, especially in older adults or at higher doses, Armilon 1mg Tablet can cause confusion or memory impairment.
- Gastrointestinal Disturbances: Nausea, vomiting, or gastrointestinal upset may occur in some individuals taking Armilon 1mg Tablet.
- Dependency: Long-term use or misuse of benzodiazepines like Armilon can lead to physical and psychological dependency, making it challenging to discontinue the medication without experiencing withdrawal symptoms.
- Respiratory Depression: In rare cases, particularly when taken in high doses or in combination with other central nervous system depressants like alcohol or opioids, Armilon 1mg Tablet can suppress respiratory function, leading to breathing difficulties or even respiratory failure.
References
- Mylan, Electronic medicines compendium (EMC), [Revised on March 2021], [Accessed on Feb 16th, 2023], https://www.medicines.org.uk/emc/files/pil.2749.pdf
- Junmei Cairns; Anastrozole regulates fatty acid synthase in breast cancer; Published on Oct 2021; [Accessed on 16th Feb 2023];https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742770/
- ARIMIDEX, U.S Food & Drug Administration FDA, [Revised on Oct 2010] [ Accessed on Feb 16th, 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf
Disclaimer
Singhla Medicos’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.
Reviews
There are no reviews yet.